PLIANT THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.81 USD | 0.00% |
|
-1.22% | -23.74% |
Chart calendar Pliant Therapeutics, Inc.
8e406f40a33f3c30449682.9SHEmvpr9VAGwNxjfXmOE8wMbYnCVl6G0WjQpMUidiM.2Fa-7oszkSp2gulUNku8Q75TIfmJPhrN4F3kkvdaF2axVfLPqTyXKW-y7A~7c8e64b9a2519982dd7e5c4b2d32aead
Upcoming events on Pliant Therapeutics, Inc.
Past events on Pliant Therapeutics, Inc.
| 2024-05-06 04:05 pm | Q1 2024 Earnings Release |
| 2024-04-16 | Piper Sandler Spring Biopharma Symposium |
| 2024-04-09 11:45 am | Needham Healthcare Conference |
| 2024-03-12 04:20 pm | Leerink Partners Global Biopharma Conference |
| 2024-03-05 12:50 pm | TD Cowen Health Care Conference |
| 2024-02-27 | Wells Fargo West Coast Biotech Tour |
| 2024-02-27 04:03 pm | Q4 2023 Earnings Release |
| 2024-02-13 12:00 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2024-02-05 08:00 am | INTEGRIS-PSC Phase 2a Trial Results Call |
| 2024-01-09 10:30 am | JPMorgan Healthcare Conference |
| 2023-11-30 09:00 am | Piper Sandler Healthcare Conference |
| 2023-11-28 | Evercore ISI HealthCONx Conference |
| 2023-11-15 01:15 pm | Stifel Healthcare Conference |
| 2023-11-13 05:00 pm | American Association for the Study of Liver Diseases Conference - Abstract #5008 |
| 2023-11-09 04:05 pm | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract No 464 |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract No: 714 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract No: 1467 |
| 2023-09-28 11:30 am | Cantor Global Healthcare Conference |
| 2023-09-26 08:00 am | INTEGRIS PSC Phase 2a Trial Results Call |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 41,8 39,4 6.04% | 7,57 7,72 -1.96% | 9,69 8,99 7.71% | 1,58 2,45 -35.43% | 1,54 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -125 -123 -2.28% | -182 -186 2.23% | -213 |
|
EBIT Million USD | Released Forecast Spread | -41,6 -49,3 15.58% | -20,0 -101 80.12% | -127 -124 -2.92% | -184 -187 1.39% | -221 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,5 -61,0 31.91% | -19,7 -101 80.41% | -123 -122 -1.3% | -161 -170 5.34% | -208 |
|
Net income Million USD | Released Forecast Spread | -41,5 -61,0 31.91% | -19,7 -101 80.41% | -123 -122 -1.25% | -161 -170 5.06% | -208 |
|
EPS USD | Released Forecast Spread | -1,95 -2,90 32.76% | -2,71 -2,80 3.33% | -2,94 -2,89 -1.79% | -2,75 -2,91 5.34% | -3,42 |
| Announcement Date | 16/03/21 | 28/02/22 | 09/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,25 1,05 18.95% | 4,99 1,20 315.79% | 1,48 1,59 -6.98% | 1,97 1,17 68.12% | 1,33 0,88 50.82% | 0,25 0,90 -72.36% | 0,00 0,63 - | 0,00 0,46 - | 0,00 0,39 - | 0,37 | 0,39 | 0,89 | 0,50 | 0,50 |
|
EBITDA Million USD | Released Forecast Spread | -51,9 -50,0 -3.76% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -28,2 -27,6 -2.33% | -29,6 -29,5 -0.61% | -31,9 -33,7 5.19% | -37,4 -33,5 -11.52% | -42,1 -37,3 -12.79% | -47,3 -42,5 -11.38% | -47,7 -48,3 1.29% | -47,0 -50,1 6.14% | -52,4 -49,1 -6.79% | -53,8 | -55,6 | -56,5 | -59,2 | -61,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,1 -27,6 -1.95% | -29,5 -29,6 0.16% | -30,6 -34,2 10.42% | -35,1 -33,5 -4.68% | -37,5 -36,7 -2.3% | -41,2 -41,1 -0.12% | -41,5 -47,6 12.86% | -41,1 -50,9 19.26% | -47,0 -46,7 -0.6% | -51,8 | -53,9 | -55,6 | -57,5 | -59,8 |
|
Net income Million USD | Released Forecast Spread | -28,1 -27,6 -1.9% | -29,5 -29,4 -0.5% | -30,6 -34,0 9.95% | -35,1 -33,5 -4.62% | -37,5 -36,9 -1.8% | -41,2 -41,3 0.32% | -41,5 -47,1 11.91% | -41,1 -50,2 18.17% | -47,0 -46,5 -1.04% | -51,3 | -53,4 | -54,8 | -57,5 | -59,8 |
|
EPS USD | Released Forecast Spread | -0,78 -0,75 -3.54% | -0,82 -0,81 -1.08% | -0,65 -0,74 12.16% | -0,72 -0,70 -3.17% | -0,67 -0,67 0% | -0,70 -0,71 1.73% | -0,70 -0,78 10.67% | -0,69 -0,82 16.11% | -0,78 -0,77 -0.7% | -0,86 | -0,89 | -0,91 | -0,86 | -0,90 |
| Announcement Date | 09/05/22 | 08/08/22 | 08/11/22 | 09/03/23 | 09/05/23 | 09/08/23 | 09/11/23 | 27/02/24 | 06/05/24 | - | - | - | - | - |
More events
Past sector events for Pliant Therapeutics, Inc.
| 2024-05-10 11:01 am | PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-10 06:50 am | ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-10 06:46 am | NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-09 | NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-09 | KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-09 | JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-09 | TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:02 pm | COLLEGIUM PHARMACEUTICAL, INC.: Q1 2024 Earnings Release |
| 2024-05-09 09:58 am | SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release |
| 2024-05-09 09:06 am | ABBOTT INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PLRX Stock
- Calendar Pliant Therapeutics, Inc.
